Article

January 27, 2023

AJMC® in the Press, January 27, 2023

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A study published in the November 2022 issue of The American Journal of Managed Care^® was cited in articles by Earth.com and MedicalXpress. The study, “COVID-19 Surges and Hospital Outcomes in the United States,” found increased hospital mortality odds among non–COVID-19 patients, implying compromised quality of care during COVID-19 surges. Additionally, no large-scale changes were found in discharges to other facilities.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos

Richard Lafayette, MD, FACP, Stanford

Eric Lander, MD

Dr Ashley Yocum

Lorna Warwick

Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia

Related Content

puzzle made of money with missing piece saying "obesity" | Image credit: Dzmitry – stock.adobe.com

June 24th 2025

Patients With Obesity Face Higher Financial Burden, Food Insecurity

Hayden E. Klein

Data from 2019 to 2023 show 9.2% of adults with obesity reported cost-related medication adherence.

Managed Care Cast

June 24th 2025

Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care

Giuliana Grossi Skylar Jeremias Eva Szigethy, MD, PhD Benjamin Cohen, MD

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.

Marginal zone lymphoma | Image: Atlas of Hematological Cytology

June 24th 2025

In R/R Marginal Zone Lymphoma, 90% Alive at 2 Years After Liso-Cel

In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in relapsed marginal zone lymphoma, offering hope for improved patient outcomes in challenging cases.

June 19th 2025

Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays

Maggie L. Shaw Colin Banas, MD, MHA

Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.

Stressed older woman | Image credit: InsideCreativeHouse – stock.adobe.com

June 24th 2025

Musculoskeletal Disorders in Postmenopausal Women Are Rising Worldwide

Hayden E. Klein

Osteoarthritis leads the burden, projected to affect 50% of postmenopausal women by 2045.

Richard J. Nowak, MD, MS | Image Credit: Yale School of Medicine

June 24th 2025

Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS

Maggie L. Shaw Richard J. Nowak, MD, MS

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.

Related Content

puzzle made of money with missing piece saying "obesity" | Image credit: Dzmitry – stock.adobe.com

June 24th 2025

Patients With Obesity Face Higher Financial Burden, Food Insecurity

Hayden E. Klein

Data from 2019 to 2023 show 9.2% of adults with obesity reported cost-related medication adherence.

Managed Care Cast

June 24th 2025

Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care

Giuliana Grossi Skylar Jeremias Eva Szigethy, MD, PhD Benjamin Cohen, MD

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.

Marginal zone lymphoma | Image: Atlas of Hematological Cytology

June 24th 2025

In R/R Marginal Zone Lymphoma, 90% Alive at 2 Years After Liso-Cel

In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in relapsed marginal zone lymphoma, offering hope for improved patient outcomes in challenging cases.

June 19th 2025

Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays

Maggie L. Shaw Colin Banas, MD, MHA

Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.

Stressed older woman | Image credit: InsideCreativeHouse – stock.adobe.com

June 24th 2025

Musculoskeletal Disorders in Postmenopausal Women Are Rising Worldwide

Hayden E. Klein

Osteoarthritis leads the burden, projected to affect 50% of postmenopausal women by 2045.

Richard J. Nowak, MD, MS | Image Credit: Yale School of Medicine

June 24th 2025

Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS

Maggie L. Shaw Richard J. Nowak, MD, MS

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions